Akinchan Bhardwaj։ OCEANIC-STROKE Trial Signals a New Era in Secondary Stroke Prevention
Akinchan Bhardwaj, Consultant Interventional Cardiologist at Kauvery Hospital, shared a post on LinkedIn:
”A new antithrombotic strategy may finally reduce recurrent ischemic stroke without increasing bleeding
At the American Stroke Association International Stroke Conference 2026, the OCEANIC-STROKE trial presented an important signal in secondary stroke prevention.
Asundexian, a Factor XIa inhibitor, when added to standard antiplatelet therapy, reduced recurrent ischemic stroke without increasing major bleeding.
Key takeaways from this late-breaking abstract:
- ~26% relative reduction in recurrent ischemic stroke
- Reduction in disabling stroke
- No increase in intracranial or major bleeding
- Consistent benefit across age, sex, and stroke subtype
- Favorable composite cardiovascular outcomes
Why this matters:
For decades, efforts to intensify antithrombotic therapy after non-cardioembolic ischemic stroke have been constrained by bleeding risk. FXIa inhibition targets thrombosis biology more selectively, potentially separating efficacy from hemorrhage: “a long-standing unmet need”in stroke prevention.
Important context:
• Phase III, >12,000 patients, global trial
• Non-cardioembolic ischemic stroke / high-risk TIA
• Results are preliminary (conference abstract, not yet peer-reviewed)
If confirmed, FXI inhibition may represent a meaningful shift in how we think about long-term secondary stroke prevention.
Looking forward to the full manuscript and imaging substudy data.”
Stay updated with Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers